Jinling Pharmaceutical Balance Sheet Health
Finanzielle Gesundheit Kriterienprüfungen 6/6
Jinling Pharmaceutical has a total shareholder equity of CN¥4.4B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥5.4B and CN¥918.3M respectively. Jinling Pharmaceutical's EBIT is CN¥31.3M making its interest coverage ratio -1.3. It has cash and short-term investments of CN¥2.1B.
Wichtige Informationen
0%
Verhältnis von Schulden zu Eigenkapital
CN¥0
Verschuldung
| Zinsdeckungsgrad | -1.3x |
| Bargeld | CN¥2.11b |
| Eigenkapital | CN¥4.44b |
| Gesamtverbindlichkeiten | CN¥918.35m |
| Gesamtvermögen | CN¥5.36b |
Jüngste Berichte zur Finanzlage
Keine Aktualisierungen
Analyse der Finanzlage
Kurzfristige Verbindlichkeiten: 000919's short term assets (CN¥3.1B) exceed its short term liabilities (CN¥896.6M).
Langfristige Verbindlichkeiten: 000919's short term assets (CN¥3.1B) exceed its long term liabilities (CN¥21.7M).
Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital
Verschuldungsgrad: 000919 is debt free.
Schulden abbauen: 000919 had no debt 5 years ago.
Schuldendeckung: 000919 has no debt, therefore it does not need to be covered by operating cash flow.
Zinsdeckung: 000919 has no debt, therefore coverage of interest payments is not a concern.